Description

Supplementary data from the berberine visceral hypersensitivity study depicting spinal microglial activation markers. Berberine administration appears associated with suppressed microglial responses in the spinal cord of rat models.

Figure 8

Chart

Source Paper

Berberine alleviates visceral hypersensitivity in rats by altering gut microbiome and suppressing spinal microglial activation.

Acta pharmacologica Sinica (2021)

PMID: 33558654

DOI: 10.1038/s41401-020-00601-4

Cite This Figure

![Figure 8: Supplementary data from the berberine visceral hypersensitivity study depicting spinal microglial activation markers. Berberine administration appears associated with suppressed microglial responses in the spinal cord of rat models.]()

> Source: Jin-Dong Zhang et al. "Berberine alleviates visceral hypersensitivity in rats by altering gut microbiom." *Acta pharmacologica Sinica*, 2021. PMID: [33558654](https://pubmed.ncbi.nlm.nih.gov/33558654/)

<figure>
  <img src="" alt="Supplementary data from the berberine visceral hypersensitivity study depicting spinal microglial activation markers. Berberine administration appears associated with suppressed microglial responses in the spinal cord of rat models." />
  <figcaption>Figure 8. Supplementary data from the berberine visceral hypersensitivity study depicting spinal microglial activation markers. Berberine administration appears associated with suppressed microglial responses in the spinal cord of rat models.<br>  Source: Jin-Dong Zhang et al. "Berberine alleviates visceral hypersensitivity in rats by altering gut microbiom." <em>Acta pharmacologica Sinica</em>, 2021. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/33558654/">33558654</a></figcaption>
</figure>

Related Evidence

Berberine for Gut Dysbiosis

Grade D · 2 studies